menu
    • menu

    Company profile for Microbion

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Microbion is a clinical-stage pharmaceutical company developing a novel class of microbial bioenergetic inhibitors for the treatment of resistant and difficult to treat infections. Pravibismane, our first therapeutic candidate, has demonstrated in vitro broad spectrum, anti-bacterial efficacy against clinically relevant pathogens, including multiple priority pathogens or “superbugs” identified by the US Centers for Disease...
    Microbion is a clinical-stage pharmaceutical company developing a novel class of microbial bioenergetic inhibitors for the treatment of resistant and difficult to treat infections. Pravibismane, our first therapeutic candidate, has demonstrated in vitro broad spectrum, anti-bacterial efficacy against clinically relevant pathogens, including multiple priority pathogens or “superbugs” identified by the US Centers for Disease Control and Prevention (CDC). In addition, pravibismane also has demonstrated the ability to prevent and eradicate microbial biofilms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MicrobionUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 West Mendenhall Street, Suite 202 Bozeman, MT 59715
    Telephone
    Telephone
    406 233 6472
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://microbioncorp.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Microbion Reports Positive Phase 2 Data for Diabetic Foot Ulcers
    Microbion Reports Positive Phase 2 Data for Diabetic Foot Ulcers

    13 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-announces-positive-topline-results-from-phase-2-study-of-topical-pravibismane-for-moderately-infected-diabetic-foot-ulcers-302303634.html

    PR NEWSWIRE
    13 Nov 2024
    Share Share
    Microbion Receives Award at Advanced Wound Care Summit USA's Innovation Showcase
    Microbion Receives Award at Advanced Wound Care Summit USA's Innovation Showcase

    25 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-receives-award-at-advanced-wound-care-summit-usas-innovation-showcase-302126822.html

    PR NEWSWIRE
    25 Apr 2024
    Share Share
    Microbion Selected For Advanced Wound Care Summit USA
    Microbion Selected For Advanced Wound Care Summit USA

    15 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-selected-to-present-at-advanced-wound-care-summit-usa-302115810.html

    PR NEWSWIRE
    15 Apr 2024
    Share Share
    Microbion Pravibismane Ph 1b DFU Published in International Wound Journal
    Microbion Pravibismane Ph 1b DFU Published in International Wound Journal

    04 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbions-topical-pravibismane-phase-1b-moderate-or-severe-diabetic-foot-ulcer-infection-study-is-published-in-international-wound-journal-302107893.html

    PR NEWSWIRE
    04 Apr 2024
    Share Share
    Microbion's Pravibismane Granted Second FDA Orphan Drug Designation
    Microbion's Pravibismane Granted Second FDA Orphan Drug Designation

    30 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbions-pravibismane-granted-second-fda-orphan-drug-designation-for-the-treatment-of-non-tuberculous-mycobacterial-ntm-infections-302045880.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    Microbion CEO to Participate in Panel Discussion at BioFuture 2023
    Microbion CEO to Participate in Panel Discussion at BioFuture 2023

    05 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-ceo-to-participate-in-panel-discussion-at-biofuture-2023-301948763.html

    PR NEWSWIRE
    05 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search